Li, J.; Xiong, Y.; Cheng, S.; Liu, D.; Wei, Q.; Ye, X.
Jingangteng Capsule Attenuates Ulcerative Colitis via Maintaining the Homeostasis of Intestinal Microbiota and Metabolites, Inhibiting the PI3K-AKT-mTOR Signaling Pathway. Pharmaceuticals 2026, 19, 589.
https://doi.org/10.3390/ph19040589
AMA Style
Li J, Xiong Y, Cheng S, Liu D, Wei Q, Ye X.
Jingangteng Capsule Attenuates Ulcerative Colitis via Maintaining the Homeostasis of Intestinal Microbiota and Metabolites, Inhibiting the PI3K-AKT-mTOR Signaling Pathway. Pharmaceuticals. 2026; 19(4):589.
https://doi.org/10.3390/ph19040589
Chicago/Turabian Style
Li, Jing, Yue Xiong, Shiyuan Cheng, Dan Liu, Qiong Wei, and Xiaochuan Ye.
2026. "Jingangteng Capsule Attenuates Ulcerative Colitis via Maintaining the Homeostasis of Intestinal Microbiota and Metabolites, Inhibiting the PI3K-AKT-mTOR Signaling Pathway" Pharmaceuticals 19, no. 4: 589.
https://doi.org/10.3390/ph19040589
APA Style
Li, J., Xiong, Y., Cheng, S., Liu, D., Wei, Q., & Ye, X.
(2026). Jingangteng Capsule Attenuates Ulcerative Colitis via Maintaining the Homeostasis of Intestinal Microbiota and Metabolites, Inhibiting the PI3K-AKT-mTOR Signaling Pathway. Pharmaceuticals, 19(4), 589.
https://doi.org/10.3390/ph19040589
